Product NDC: | 16477-106 |
Proprietary Name: | Donatussin DROPS |
Non Proprietary Name: | Phenylephrine Hydrochloride, Guaifenesin |
Active Ingredient(s): | 20; 1.5 mg/mL; mg/mL & nbsp; Phenylephrine Hydrochloride, Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16477-106 |
Labeler Name: | Laser Pharmaceuticals, LLC |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20051220 |
Package NDC: | 16477-106-30 |
Package Description: | 1 BOTTLE in 1 CARTON (16477-106-30) > 30 mL in 1 BOTTLE |
NDC Code | 16477-106-30 |
Proprietary Name | Donatussin DROPS |
Package Description | 1 BOTTLE in 1 CARTON (16477-106-30) > 30 mL in 1 BOTTLE |
Product NDC | 16477-106 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Phenylephrine Hydrochloride, Guaifenesin |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20051220 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Laser Pharmaceuticals, LLC |
Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 20; 1.5 |
Strength Unit | mg/mL; mg/mL |
Pharmaceutical Classes |